ArticleAnnals of hematology2025

Ruxolitinib for pediatric acute and chronic graft-versus-host disease: a single-center retrospective study of efficacy and safety.

Chiao-Yu Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.